
Pharma’s ad tax deductibility remains in the crosshairs
A potential pharma TV ad ban isn’t the only regulatory action under consideration in Washington, D.C. that has medical marketers on alert. Leadership within the Beltway has considered stripping the industry of one of its tax benefits — an ability to deduct …